The healthcare sector is receiving more attention from the brokerage community now that the healthcare reform law is under review this year. This morning, analysts reviewed the following public healthcare companies and issued their near-term assessments:

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG): Roth Capital says buyAMAG Pharma on weakness. After taking a look at guidance for the fourth quarter and current year, Roth Capital sees AMAG as a takeover target. The firm reiterates a Buy and a target of $25.

IPC The Hospitalist Company, Inc. (NASDAQ:IPCM): Piper Jaffray lowered IPCM’s target from $49 to $39. Pre-announcement prompted a sell-off yesterday, but Piper Jaffray says the sell-off was overdone and still believes the company has a growth story. The firm maintains an Overweight.

To contact the reporter on this story: Jim Wilkerson at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com